{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:36:45Z","timestamp":1789501005457,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007087","name":"University of Isfahan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007087","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-026-01113-3","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T09:17:25Z","timestamp":1772443045000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Crossing ocular barriers with quercetin-SPIONs: modulation of Bax\/Bcl-2 balance in normal rat eyes"],"prefix":"10.1186","volume":"27","author":[{"given":"Mahtab","family":"Hajiaghajanian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazanin","family":"Movahedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorsa","family":"Pouriaii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Souri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azam","family":"Rezayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abolghasem","family":"Esmaeili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"key":"1113_CR1","first-page":"315","volume":"53","author":"Z Sahnoun","year":"1998","unstructured":"Sahnoun Z, Jamoussi K, Zeghal KM. [Free radicals and antioxidants: physiology, human pathology and therapeutic aspects (part II)]. Therapie. 1998;53:315\u201339.","journal-title":"Therapie"},{"key":"1113_CR2","doi-asserted-by":"publisher","first-page":"102967","DOI":"10.1016\/j.redox.2023.102967","volume":"68","author":"EW B\u00f6hm","year":"2023","unstructured":"B\u00f6hm EW, Buonfiglio F, Voigt AM, Bachmann P, Safi T, Pfeiffer N, Gericke A. Oxidative stress in the eye and its role in the pathophysiology of ocular diseases. Redox Biol. 2023;68:102967.","journal-title":"Redox Biol"},{"key":"1113_CR3","doi-asserted-by":"crossref","unstructured":"Rodella U, Honisch C, Gatto C, Ruzza P, D\u2019Amato T\u00f3thov\u00e1 J. Antioxidant nutraceutical strategies in the prevention of oxidative stress related eye diseases. Nutrients. 2023;15.","DOI":"10.3390\/nu15102283"},{"key":"1113_CR4","doi-asserted-by":"crossref","unstructured":"Russo C, Rusciano D, Santangelo R, Malaguarnera L. Options for topical treatment of oxidative eye diseases with a special focus on retinopathies. Med (Kaunas). 2024;60.","DOI":"10.3390\/medicina60030354"},{"key":"1113_CR5","doi-asserted-by":"publisher","first-page":"97547","DOI":"10.1039\/C5RA18896B","volume":"5","author":"P Mukhopadhyay","year":"2015","unstructured":"Mukhopadhyay P, Prajapati A. Quercetin in anti-diabetic research and strategies for improved quercetin bioavailability using polymer-based carriers\u2013a review. RSC Adv. 2015;5:97547\u201362.","journal-title":"RSC Adv"},{"key":"1113_CR6","doi-asserted-by":"crossref","unstructured":"Aghababaei F, Hadidi M. Recent advances in potential health benefits of quercetin. Pharmaceuticals(Basel). 2023;16.","DOI":"10.3390\/ph16071020"},{"key":"1113_CR7","first-page":"242","volume":"20","author":"R Chen","year":"2014","unstructured":"Chen R, Hollborn M, Grosche A, Reichenbach A, Wiedemann P, Bringmann A, Kohen L. Effects of the vegetable polyphenols epigallocatechin-3-gallate, luteolin, apigenin, myricetin, quercetin, and cyanidin in primary cultures of human retinal pigment epithelial cells. Mol Vis. 2014;20:242.","journal-title":"Mol Vis"},{"key":"1113_CR8","doi-asserted-by":"publisher","first-page":"4001","DOI":"10.1021\/jf903038r","volume":"58","author":"W Kalt","year":"2010","unstructured":"Kalt W, Hanneken A, Milbury P, Tremblay F. Recent research on polyphenolics in vision and eye health. J Agric Food Chem. 2010;58:4001\u20137.","journal-title":"J Agric Food Chem"},{"key":"1113_CR9","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.exer.2007.11.009","volume":"86","author":"P Maher","year":"2008","unstructured":"Maher P, Hanneken A. Flavonoids protect retinal ganglion cells from ischemia in vitro. Exp Eye Res. 2008;86:366\u201374.","journal-title":"Exp Eye Res"},{"key":"1113_CR10","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1211\/jpp.62.08.0001","volume":"62","author":"S Majumdar","year":"2010","unstructured":"Majumdar S, Srirangam R. Potential of the bioflavonoids in the prevention\/treatment of ocular disorders. J Pharm Pharmacol. 2010;62:951\u201365.","journal-title":"J Pharm Pharmacol"},{"key":"1113_CR11","doi-asserted-by":"publisher","first-page":"651441","DOI":"10.3389\/fnut.2021.651441","volume":"8","author":"S Davinelli","year":"2021","unstructured":"Davinelli S, Ali S, Scapagnini G, Costagliola C. Effects of Flavonoid Supplementation on Common Eye Disorders: A Systematic Review and Meta-Analysis of Clinical Trials. Front Nutr. 2021;8:651441.","journal-title":"Front Nutr"},{"key":"1113_CR12","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.ejphar.2008.03.008","volume":"585","author":"AW Boots","year":"2008","unstructured":"Boots AW, Haenen GR, Bast A. Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol. 2008;585:325\u201337.","journal-title":"Eur J Pharmacol"},{"key":"1113_CR13","doi-asserted-by":"publisher","first-page":"110372","DOI":"10.1016\/j.biopha.2020.110372","volume":"128","author":"Y Wang","year":"2020","unstructured":"Wang Y, Tao B, Wan Y, Sun Y, Wang L, Sun J, Li C. Drug delivery based pharmacological enhancement and current insights of quercetin with therapeutic potential against oral diseases. Biomed Pharmacother. 2020;128:110372.","journal-title":"Biomed Pharmacother"},{"key":"1113_CR14","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jconrel.2023.08.018","volume":"362","author":"KK Abla","year":"2023","unstructured":"Abla KK, Mehanna MM. Lipid-based nanocarriers challenging the ocular biological barriers: Current paradigm and future perspectives. J Control Release. 2023;362:70\u201396.","journal-title":"J Control Release"},{"key":"1113_CR15","doi-asserted-by":"crossref","unstructured":"Moiseev RV, Morrison PWJ, Steele F, Khutoryanskiy VV. Penetration enhancers in ocular drug delivery. Pharmaceutics. 2019;11.","DOI":"10.3390\/pharmaceutics11070321"},{"key":"1113_CR16","doi-asserted-by":"publisher","first-page":"108255","DOI":"10.1016\/j.exer.2020.108255","volume":"201","author":"TC Chan","year":"2020","unstructured":"Chan TC, Wilkinson Berka JL, Deliyanti D, Hunter D, Fung A, Liew G, White A. The role of reactive oxygen species in the pathogenesis and treatment of retinal diseases. Exp Eye Res. 2020;201:108255.","journal-title":"Exp Eye Res"},{"issue":"12","key":"1113_CR17","doi-asserted-by":"publisher","first-page":"3316","DOI":"10.3390\/pr11123316","volume":"11","author":"X Wu","year":"2023","unstructured":"Wu X, Ciannella S, Choe H, Strayer J, Wu K, Chalmers J, Gomez-Pastora J. SPIONs Magnetophoresis and Separation via Permanent Magnets: Biomedical and Environmental Applications. Processes. 2023;11(12):3316.","journal-title":"Processes"},{"key":"1113_CR18","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/1097-4636(20000905)51:3<343::AID-JBM7>3.0.CO;2-D","volume":"51","author":"NA Alcantar","year":"2000","unstructured":"Alcantar NA, Aydil ES, Israelachvili JN. Polyethylene glycol-coated biocompatible surfaces. J Biomed Mater Res. 2000;51:343\u201351.","journal-title":"J Biomed Mater Res"},{"key":"1113_CR19","doi-asserted-by":"crossref","unstructured":"Mylkie K, Nowak P, Rybczynski P, Ziegler-Borowska M. Polymer-coated magnetite nanoparticles for protein immobilization. Mater (Basel). 2021;14.","DOI":"10.3390\/ma14020248"},{"key":"1113_CR20","doi-asserted-by":"crossref","unstructured":"Maharat Z, Esmaeili A, Kafrani AT. Quercetin-SPIONs enhance neuroprotection in aged rat tMCAO model via modulation of GABA B receptor and CHOP mRNA expression. J Drug Deliv Sci Technol. 2025:107310.","DOI":"10.1016\/j.jddst.2025.107310"},{"key":"1113_CR21","doi-asserted-by":"publisher","first-page":"3164734","DOI":"10.1155\/2016\/3164734","volume":"2016","author":"M Nita","year":"2016","unstructured":"Nita M, Grzybowski A. The Role of the Reactive Oxygen Species and Oxidative Stress in the Pathomechanism of the Age-Related Ocular Diseases and Other Pathologies of the Anterior and Posterior Eye Segments in Adults. Oxid Med Cell Longev. 2016;2016:3164734.","journal-title":"Oxid Med Cell Longev"},{"key":"1113_CR22","doi-asserted-by":"crossref","unstructured":"Dinice L, Cosimi P, Esposito G, Scarinci F, Cacciamani A, Cafiero C, Placentino L, Ripandelli G, Micera A. Oxidative stress and complement activation in aqueous cells and vitreous from patient with vitreoretinal diseases: comparison between diabetic ERM and PDR. Antioxid (Basel). 2025;14.","DOI":"10.3390\/antiox14070841"},{"key":"1113_CR23","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.21037\/tp-24-193","volume":"13","author":"B Sun","year":"2024","unstructured":"Sun B, Cai F, Yu L, An R, Wei B, Li M. Quercetin inhibits ferroptosis through the SIRT1\/Nrf2\/HO-1 signaling pathway and alleviates asthma disease. Transl Pediatr. 2024;13:1747\u201359.","journal-title":"Transl Pediatr"},{"key":"1113_CR24","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s10787-023-01416-5","volume":"32","author":"X Jia","year":"2024","unstructured":"Jia X, Gu M, Dai J, Wang J, Zhang Y, Pang Z. Quercetin attenuates Pseudomonas aeruginosa-induced acute lung inflammation by inhibiting PI3K\/AKT\/NF-\u03baB signaling pathway. Inflammopharmacology. 2024;32:1059\u201376.","journal-title":"Inflammopharmacology"},{"key":"1113_CR25","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.1007\/s13346-024-01544-7","volume":"14","author":"M Li","year":"2024","unstructured":"Li M, Li H, Lu L, Fu J, Ao H, Han M, Guo Y, Zhang H, Wang Z, Wang X. Simple preparation and significantly improved oral bioavailability: The supersaturated drug delivery system of quercetin based on PVP K30. Drug Deliv Transl Res. 2024;14:3225\u201338.","journal-title":"Drug Deliv Transl Res"},{"key":"1113_CR26","doi-asserted-by":"crossref","unstructured":"Zhuo Y, Zhao YG, Zhang Y. Enhancing drug solubility, bioavailability, and targeted therapeutic applications through magnetic nanoparticles. Molecules. 2024;29.","DOI":"10.3390\/molecules29204854"},{"key":"1113_CR27","doi-asserted-by":"publisher","first-page":"123936","DOI":"10.1016\/j.ijpharm.2024.123936","volume":"654","author":"A Pant","year":"2024","unstructured":"Pant A, Singh G, Barnwal RP, Sharma T, Singh B. QbD-driven development and characterization of superparamagnetic iron oxide nanoparticles (SPIONS) of a bone-targeting peptide for early detection of osteoporosis. Int J Pharm. 2024;654:123936.","journal-title":"Int J Pharm"},{"key":"1113_CR28","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s11468-023-01994-8","volume":"19","author":"A Al-Abboodi","year":"2024","unstructured":"Al-Abboodi A, Albukhaty S, Sulaiman GM, Al-Saady MA, Jabir MS, Abomughaid MM. Protein conjugated superparamagnetic iron oxide nanoparticles for efficient vaccine delivery systems. Plasmonics. 2024;19:379\u201388.","journal-title":"Plasmonics"},{"key":"1113_CR29","doi-asserted-by":"publisher","first-page":"16094","DOI":"10.1039\/c1jm11270h","volume":"21","author":"C Huang","year":"2011","unstructured":"Huang C, Neoh KG, Kang E-T, Shuter B. Surface modified superparamagnetic iron oxide nanoparticles (SPIONs) for high efficiency folate-receptor targeting with low uptake by macrophages. J Mater Chem. 2011;21:16094\u2013102.","journal-title":"J Mater Chem"},{"key":"1113_CR30","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3390\/jnt1010008","volume":"1","author":"NR Nelson","year":"2020","unstructured":"Nelson NR, Port JD, Pandey MK. Use of superparamagnetic iron oxide nanoparticles (SPIONs) via multiple imaging modalities and modifications to reduce cytotoxicity: an educational review. J Nanotheranostics. 2020;1:105\u201335.","journal-title":"J Nanotheranostics"},{"key":"1113_CR31","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1557\/s43578-025-01528-4","volume":"40","author":"J Wang","year":"2025","unstructured":"Wang J, Shi X, Hou S, Wang Y, Xu Z, He M, Liu Y, Ge F, Li R, Wang J. Photocatalytic antibacterial properties and mechanism of PEG-modified superparamagnetic iron oxide nanoparticles. J Mater Res. 2025;40:689\u2013703.","journal-title":"J Mater Res"},{"key":"1113_CR32","doi-asserted-by":"crossref","unstructured":"Nikolaidou A, Spyratou E, Sandali A, Gianni T, Platoni K, Lamprogiannis L, Efstathopoulos EP. Utilization of nanoparticles for treating age-related macular degeneration. Pharmaceuticals (Basel). 2025;18.","DOI":"10.3390\/ph18020162"},{"key":"1113_CR33","first-page":"230","volume":"32","author":"A Yava\u015f","year":"2025","unstructured":"Yava\u015f A. Fig Seed Oil Induces Mitochondrial-Mediated Apoptosis in HepG2 Cells. Med J S\u00fcleyman Demirel Univ. 2025;32:230\u20139.","journal-title":"Med J S\u00fcleyman Demirel Univ"},{"key":"1113_CR34","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez-L\u00e1zaro D, Sanz B, Seco-Calvo J. The mechanisms of regulated cell death: structural and functional proteomic pathways induced or inhibited by a specific protein-a narrative review. Proteomes. 2024;12.","DOI":"10.3390\/proteomes12010003"},{"key":"1113_CR35","doi-asserted-by":"crossref","unstructured":"Yang TH, Kang EY, Lin PH, Yu BB, Wang JH, Chen V, Wang NK. Mitochondria in retinal ganglion cells: unraveling the metabolic nexus and oxidative stress. Int J Mol Sci. 2024;25.","DOI":"10.3390\/ijms25168626"},{"key":"1113_CR36","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1007\/s11033-024-09425-5","volume":"51","author":"M Zhang","year":"2024","unstructured":"Zhang M, Zhang R, Zhao X, Ma Z, Xin J, Xu S, Guo D. The role of oxidative stress in the pathogenesis of ocular diseases: an overview. Mol Biol Rep. 2024;51:454.","journal-title":"Mol Biol Rep"},{"key":"1113_CR37","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s11033-024-09805-x","volume":"51","author":"SM Khadrawy","year":"2024","unstructured":"Khadrawy SM, Altoom NG, Alotaibi AG, Othman SI. Hepatoprotective potential of taxifolin in type 2 diabetic rats: modulation of oxidative stress and Bcl2\/Bax\/Caspase-3 signaling pathway. Mol Biol Rep. 2024;51:897.","journal-title":"Mol Biol Rep"},{"key":"1113_CR38","doi-asserted-by":"publisher","first-page":"178177","DOI":"10.1016\/j.ejphar.2025.178177","volume":"1006","author":"DI El-Wafaey","year":"2025","unstructured":"El-Wafaey DI, Talaat A, El-Malkey NF, Abdelhamid AM, Ibrahim F, Zaazaa AM, Faruk E. Quercetin attenuates busulfan-induced testicular and epididymal toxicity via modulation of oxidative stress, inflammatory cytokines, and apoptotic markers in rats. Eur J Pharmacol. 2025;1006:178177.","journal-title":"Eur J Pharmacol"},{"key":"1113_CR39","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41573-024-00958-9","volume":"23","author":"T Kenakin","year":"2024","unstructured":"Kenakin T. Know your molecule: pharmacological characterization of drug candidates to enhance efficacy and reduce late-stage attrition. Nat Rev Drug Discov. 2024;23:626\u201344.","journal-title":"Nat Rev Drug Discov"},{"key":"1113_CR40","doi-asserted-by":"crossref","unstructured":"Ricci A, Stefanuto L, Gasperi T, Bruni F, Tofani D. Lipid Nanovesicles for antioxidant delivery in skin: liposomes, ufasomes, ethosomes, and niosomes. Antioxid (Basel). 2024;13.","DOI":"10.3390\/antiox13121516"},{"key":"1113_CR41","doi-asserted-by":"crossref","unstructured":"Kamali H, Jafari Z, Teymouri M, Rezaee H, Khordad E, Mosafer J. Theranostic potential and safety assessment of epirubicin-loaded SPIONs\/PLGA-PEG nanoparticles in rabbit. J Pharm Invest. 2025:1\u201315.","DOI":"10.1007\/s40005-025-00751-9"},{"key":"1113_CR42","unstructured":"Girouard G. Exploring cell cycle dynamics in retinal vascular diseases. 2025."}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-026-01113-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-026-01113-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-026-01113-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T13:25:19Z","timestamp":1775568319000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40360-026-01113-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1113"],"URL":"https:\/\/doi.org\/10.1186\/s40360-026-01113-3","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]},"assertion":[{"value":"17 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were carried out in accordance with the guidelines for the care and use of laboratory animals and received approval from the Ethics Committee of Isfahan University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"56"}}